International Research in Infectious Diseases, including AIDS (R01)
Department of Health and Human Services
National Institutes of Health
Studies may be proposed on any aspect of infectious disease research (except clinical trials), including but not limited to: the epidemiology, natural history, pathogenesis, immunopathogenesis of infectious diseases; epidemiologic studies to define the incidence, clinical presentations, and outcomes of diseases; identification of resistance mechanisms and patterns; characterization of susceptible cohorts for a particular pathogen; pilot and feasibility studies in preparation for larger studies. NOTE: HIV/AIDS studies must address NIAID priorities described at http://www.niaid.nih.gov/about/division-aids-overview
Collaborative projects involving investigators and institutions from international sites and the U.S. are particularly encouraged; however, a U.S. partner is not required. NIH supports a number of international research programs on infectious diseases, including HIV/AIDS. For NIAID, these include the International Centers of Excellence in Research (ICERs), International Collaborations in Infectious Disease Research (ICIDRs), the Tropical Medicine Research Centers (TMRCs), the Centers of Excellence for Influenza Research and Surveillance (CEIRS), the International Centers of Excellence for Malaria Research (ICEMRS), the Tuberculosis Research Unit, the HIV Vaccine Trials Network (HVTN), the HIV Prevention Trials Network (HPTN), International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT), AIDS Clinical Trials Group (ACTG), Microbicide Trials Network (MTN), the International Epidemiologic Database to Evaluate AIDS (IeDEA), and the Centers for AIDS Research (CFAR).
This International Research in Infectious Diseases including AIDS (IRIDA) Program is intended to extend these programs by expanding the breadth of research supported at international sites and by providing support to new researchers. Applications are particularly encouraged from institutions in eligible countries where NIH has significant investments through extramural research grants, cooperative agreements or contracts or through NIH intramural programs. Current NIH or NIAID funding is not a requirement.
Applicants are strongly encouraged to establish multi-institutional collaborations and to include activities that involve the transfer of technologies and research methods, sharing of core resources including the administration of research grant programs, and expansion of linkages to other sites via attendance at national and international meetings and other methods of communication.
Note: Clinical trials will not be supported. When non-interventional clinical studies using human subjects are an element of the research proposed, NIAID policy requires that studies be monitored commensurate with the degree of potential risk to study subjects and the complexity of the study. Guidance regarding policies and standard procedures for conducting NIAID-funded and/or -sponsored clinical research can be found at the following link: https://www.niaid.nih.gov/research/dmid-clinical-research-policies or https://www.niaid.nih.gov/research/daids-clinical-research-policies-standard-procedures.
Note: Select Agents Research will not be supported. Select Agents are biological agents or toxins listed in 42 CFR Part 73, 7 CFR Part 331 and 9 CFR Part 121, or the HHS and USDA Select Agents and Toxins List.
|Posted Date:||Jan 30, 2017|
|Last Updated Date:||Feb 01, 2017|
|Original Closing Date for Applications:||Aug 22, 2019|
|Current Closing Date for Applications:||Feb 01, 2017|
|Archive Date:||Feb 02, 2017|
|Estimated Total Program Funding:|